Navigation Links
New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR
Date:5/22/2013

ion volume in DEFLECT-I was 17 x smaller than the average in the reported literature (0.39 vs. 6.45 cm3), representing a 94% reduction.
  • Maximum total lesion volume in DEFLECT-I was 95% smaller than the maximum total lesion volume in reported studies (3.94 vs. 70.3 cm3).
  • Average (mean) single lesion volume in DEFLECT-I was 65% smaller than the average of reported historical data (0.12 vs. 0.34 cm3), and average total lesion volume was 57% smaller than reported average total lesion volume in reported historical data (0.7 vs. 1.64 cm3).  
  • In addition, the brain protection by TriGuard™ was safe, with no device related adverse events, had no interference with TAVR procedure, and performed optimally covering all three cerebral branches in 87% of the cases throughout valve replacement.
    TriGuard™, the only embolic protection device designed to cover all aortic cerebral branches, is fashioned to accommodate various anatomical variations of the aortic arch.

    Keystone Heart's presence at EuroPCR, Europe's largest professional meeting specializing in interventional cardiovascular medicine, was greeted with great interest.  Focus on cardiovascular procedure related brain damage, clinically evident and silent stroke, and potential preventative measures was emphasized in additional sessions, as well as in non-affiliated scientific presentations throughout the course and congress.

    Keystone Heart's Scientific Advisory Board Meeting was held adjacent to EuroPCR.  Participating key opinion leaders reached unanimous agreement on a number of issues:

    • Stroke is a devastating adverse event after cardiovascular procedures
    • Systemic therapy is highly unlikely to prevent strokes related to dislodgement of calcified material and valve particles
    • Mechanical protection such as filte
      '/>"/>

    SOURCE Keystone Heart
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
    2. Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
    3. Rigels R348 to Initiate Phase 2 Clinical Trial in Dry Eye
    4. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
    5. Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions
    6. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
    7. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
    8. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
    9. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
    10. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
    11. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/6/2015)... LONDON , May 6, 2015 ... HIV maintenance therapy with dolutegravir and rilpivirine ... start of a Phase III clinical trial programme ... (Tivicay®) and rilpivirine (Edurant® [1] ) as maintenance ... III programme comprises two replicate studies evaluating 48 ...
    (Date:5/6/2015)... , May 6, 2015   Wilson Therapeutics ... CEO Jonas Hansson has been invited to ... the annual BioEquity Conference, this year to be held ... May 19 th . About WTX101 ... is currently in Phase 2 testing for Wilson Disease. ...
    (Date:5/6/2015)... , May 6, 2015 ... join the Wellcome Trust and the Bill & ... Kymab, a leading monoclonal antibody biopharmaceutical ... an additional US$50 million to complete a US$90 ... being invested by Woodford Patient Capital Trust plc ...
    Breaking Medicine Technology:ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10Wilson Therapeutics To Present As A "Next Wave" Company During BioEquity 2015 Conference In Vienna On May 19th 2Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4
    ... 2011  Allocate Software plc, the leading provider of workforce ... its presence in the US with the announcement that ... scheduling solution, to create and manage schedules for its ... a leading provider of a diverse range of imaging ...
    ... Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that ... present a corporate overview at the Bank of America Merrill ... at 7:30 a.m. ET.  The conference will be held at ... A live webcast and audio archive of the presentation will ...
    Cached Medicine Technology:Allocate Software's Healthroster Selected by Austin Radiological Association 2
    (Date:5/6/2015)... Launch Corporation, LLC. is pleased to announce that Launch Trampoline ... Tanguay Avenue. Owned and operated by Rick Arnold and Phil ... New England. , “We are extremely excited for Rick and ... and CEO of Launch. “They have established great roots in ... continue to establish that positive growth in the greater Nashua ...
    (Date:5/6/2015)... May 06, 2015 The SGNY Group ... York City, announced today that it was named a ... a presentation video produced on behalf of Intarcia Therapeutics. ... category of motion graphics. , The competition sponsored by ... over 6000 entries from 22 countries. The competition ...
    (Date:5/5/2015)... 06, 2015 It’s not your usual Veterans ... their classic cars and motorcycles to the 3rd Annual “Crusin ... 8 p.m. at the Lincoln VA Clinic, 600 S. 70th ... to check out each other’s rides, but also to talk ... and services. , Staff from the VA Nebraska-Western Iowa ...
    (Date:5/5/2015)... Private equity consultant and international research ... that its dental stem cell biobank project, Provia ... April, 2015 –and posted yet another exciting record. This ... and represents a significant 54% increase over last April ... is conducted via the Store-A-Tooth brand. The company has ...
    (Date:5/5/2015)... “Given that Hispanics are one in six people ... are a major step in the arsenal of facts documenting ... past 30 years, data have accumulated that the health of ... the urgency and the need to create new models of ... all,” said Jane L. Delgado, PhD, MS, President and CEO ...
    Breaking Medicine News(10 mins):Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2
    ... the brain could play a key role in regulating ... plaques implicated in the development of Alzheimer,s disease, according ... A group led by Domenico Pratico, professor of pharmacology ... of the protein, called 12/15-Lipoxygenase, in the brain three ...
    ... News) -- Researchers who found the earliest known ... the evolution of complex reproductive behavior in early dinosaurs. ... million years older than previously known nesting sites. It ... Massospondylus , a relative of the giant, long-necked sauropods ...
    ... (HealthDay News) -- Researchers who identified a protein that ... eventually lead to new treatments for the neurodegenerative disease. ... in neurons in the striatum, the part of the ... Parkinson,s disease in mice, the researchers found that RGS4 ...
    ... a genetic outlier, which has prevented scientists from discovering the ... Health and Yale University School of Medicine have devised a ... , the major cause of human malaria. This new approach ... and opens the door to further genetic discovery for the ...
    ... Calif. (January 25, 2012) Gardasil, the human papillomavirus ... adolescents and young adults, does not trigger autoimmune conditions ... multiple sclerosis after vaccination in young women, according to ... Medicine . Kaiser Permanente researchers used electronic health ...
    ... , WEDNESDAY, Jan. 25 (HealthDay News) -- Learning to ... with autism make plans and complete complex daily tasks, ... that people with autism can live independent, flexible lives, ... Durham University in England. The researchers compared how ...
    Cached Medicine News:Health News:Protein in the brain could be a key target in controlling Alzheimer's 2Health News:Oldest Known Dinosaur Nesting Site Found 2Health News:Protein That Controls Movement Does the Opposite in Parkinson's 2Health News:Researchers discover method to unravel malaria's genetic secrets 2Health News:Kaiser Permanente study finds Gardasil does not trigger autoimmune conditions after vaccination 2Health News:'Inner Dialogue' Might Aid People With Autism 2
    ... The AlphaPette Pipettor is the ... beyond. Offers accuracy, comfort, and reliability. ... digital volume readout sub-micrometer. Easy interchangeable ... or tiny hands. Adjustable rapid pipet ...
    ... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
    ... Thermo Labsystems was designed specifically to combine ... such as the new fast dial system ... help to define this as a new ... interchangeable handle plate offers a custom fit ...
    ... In the specialty areas ... or intensive care work, it ... in your practice. Alokas motorized ... Doppler and Tissue Harmonic Echo ...
    Medicine Products: